HARTFORD, Conn., Sept. 9, 2019 /PRNewswire/ -- Aetna, a CVS Health (NYSE: CVS) company, announced today that online voting is underway for the 2019 "Aetna Voices of Health" program at 

LOS ANGELES, Sept. 9, 2019 /PRNewswire/ -- Eyesthetica, a team of renowned oculofacial and eyelid surgery experts in the greater Los Angeles area, recently announced the addition of Dr. Christopher C. Lo to their staff. A Pennsylvania native, Dr. Lo attended grade scho

MIAMI, Sept. 9, 2019 /PRNewswire/ - Cansortium Inc. ("Cansortium" or the "Company") (CSE: TIUM), a vertically-integrated, global provider of premium-quality medical cannabis operating under the Fluent™ brand, continues to expand its Florida retail footprint with the September 9th opening of a new Fluent

ROCKVILLE, Md., Sept. 9, 2019 /PRNewswire/ -- ExeGi Pharma has announced that researchers at Columbia University Irving Medical Center and the University of Pittsburgh will be examining the effects of their high potency probiotic, Visbiome, in patients with multiple sclerosis (MS). The study will explore the ef

BRIDGEWATER, N.J., Sept. 9, 2019 /PRNewswire/ -- Nestlé Health Science announces the addition of BOOST® Soothe clear nutritional drink, designed with cancer patients for cancer patients. The innovative drink provides protein and calories as well as a cooling, soothing effect to help patients get the nutrition they need while dealing with certain sid

HOD HASHARON, Israel, Sept. 9, 2019 /PRNewswire/ -- Wize Pharma, Inc. (OTCQB: WIZP) a clinical-stage biopharmaceutical company focused on the treatment of ophthalmic disorders, today announced it has entered into an Exclusive License Agreement with U.S.-based Copernicus Therapeutics, I

FRISCO, Texas, Sept. 9, 2019 /PRNewswire/ -- Addus HomeCare Corporation (Nasdaq: ADUS) ("Addus" or the "Company"), a provider of comprehensive home care services, today announced the closing of an underwritten public offering of 2,300,000 shares of its common stock ("Common Stock"), including 300,000 shares of Common Stock sold pursuant to the exercise in ful

CUPERTINO, Calif., Sept. 9, 2019 /PRNewswire/ -- DURECT Corporation (Nasdaq: DRRX) announced today that further development of a long-acting injectable HIV investigational product utilizing

NEW YORK and SHANGHAI, Sept. 9, 2019 /PRNewswire/ -- Cellular Biomedicine Group Inc. (NASDAQ: CBMG) ("CBMG" or the "Company"), a bioph

WILLMINGTON, Del., Sept. 9, 2019 /PRNewswire/ -- NeuroRX, a phase 3 biopharma company focused on development of NRX-101, an FDA-designated Breakthrough Therapy for Severe Bipolar Depression with Acute Suicidal Ideation, will present a corporate overview at today's H.C. Wainwright 21st Annual Global Investment Conference in New York. In addition to the presentation by Dr.